31 Systematic review of the current literature on structured treatment interruptions in HIV-infected patients receiving antiretroviral therapy – implications for future HIV cure trials

31 Systematic review of the current literature on structured treatment interruptions in HIV-infected patients receiving antiretroviral therapy – implications for future HIV cure trials

Bibliographic Details
Main Authors:	M. Stecher, F. Klein, C. Lehmann, M. Platten, D. Gillor, G. Behrens, G. Fätkenheuer, J.J. Vehreschild
Format:	Article
Language:	English
Published:	Elsevier 2016-07-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020309766

Similar Items

Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
by: Samual A. Garner, et al.
Published: (2017-04-01)

Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research
by: Evelyn Y. Bonney, et al.
Published: (2021-03-01)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
by: Dubrocq G, et al.
Published: (2018-06-01)

HIV cure research in the time of COVID-19 - Antiretroviral therapy treatment interruption trials: A discussion paper
by: S. Fidler, et al.
Published: (2021-03-01)

Interruption of antiretroviral treatment in HIV-infected children
by: Gerlach, Undine Ariane
Published: (2004)

Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings
by: Jillian SY. Lau, et al.
Published: (2021-03-01)

Preventing antiretroviral treatment interruptions among HIV/AIDS patients in Africa.
by: Edward J Mills, et al.
Published: (2013-01-01)

59 Interrupting HIV treatment in cure research: scientific and ethical considerations
by: S. Garner, et al.
Published: (2016-07-01)

Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies
by: Jillian S. Y. Lau, et al.
Published: (2020-11-01)

Recruitment and ethical considerations in HIV cure trials requiring treatment interruption
by: Michael P. Arnold, et al.
Published: (2015-01-01)

Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial
by: Joanna Lewis, et al.
Published: (2017-09-01)

Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?
by: Adele S. Benzaken, et al.
Published: (2019-08-01)

Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection
by: Deeks Steven G, et al.
Published: (2005-08-01)

The knowledge about HIV/AIDS and antiretroviral treatment of patients receiving antiretroviral therapy
by: Terblanche, Lauren Muriel
Published: (2012)

Assessment of the inter-individual variation observed between patients receiving HIV antiretroviral therapy
by: Neary, M. G.
Published: (2018)

Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America
by: C. Alvarez, et al.
Published: (2010-05-01)

Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption
by: You Park, et al.
Published: (2017-11-01)

Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America
by: C Alvarez, et al.

Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals.
by: Katherine E Clarridge, et al.
Published: (2018-01-01)

Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV
by: A.L. Hill, et al.
Published: (2015-12-01)

Mitochondrial functionalism in HIV-infected children receiving antiretroviral therapy
by: Morén Núñez, Constanza
Published: (2012)

Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV.
by: Alison L Hill, et al.
Published: (2016-04-01)

HIV cure strategies: how good must they be to improve on current antiretroviral therapy?
by: Paul E Sax, et al.
Published: (2014-01-01)

Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized mice.
by: John D Ventura, et al.
Published: (2019-12-01)

HIV - Interpreted, intervened, interrupted . . .?
by: Damle S
Published: (2007-06-01)

Patient perspectives of HIV cure
by: K. MacDonald, et al.
Published: (2019-07-01)

Correction: Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV.
by: Alison L Hill, et al.
Published: (2017-07-01)

HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in China
by: Miaomiao Li, et al.
Published: (2021-02-01)

Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
by: Bernaschi Massimo, et al.
Published: (2009-10-01)

Hypertension in HIV-Infected Patients Receiving Antiretroviral Therapy in Northeast Ethiopia
by: Temesgen Fiseha, et al.
Published: (2019-01-01)

Improvement in Muscular Strength in HIV-Infected Individuals Receiving Antiretroviral Therapy
by: Takshita Sookan, et al.
Published: (2019-09-01)

Correction: HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy?
by: PLOS ONE Staff
Published: (2015-01-01)

Maternal CD4+ cell count decline after interruption of antiretroviral prophylaxis for the prevention of mother-to-child transmission of HIV.
by: Didier Ekouevi, et al.
Published: (2012-01-01)

Incidence and associated factors of HIV drug resistance in Chinese HIV-infected patients receiving antiretroviral treatment.
by: Hui Xing, et al.
Published: (2013-01-01)

A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection
by: Eugène D.M.B. Kroon, et al.
Published: (2020-09-01)

Regulatory T-lymphocyte subsets in patients with HIV-infection receiving highly active antiretroviral therapy
by: V. A. Chereshnev, et al.
Published: (2019-05-01)

Mutations Related to Antiretroviral Resistance Identified by Ultra-Deep Sequencing in HIV-1 Infected Children under Structured Interruptions of HAART.
by: Jose Manuel Vazquez-Guillen, et al.
Published: (2016-01-01)

Correction: Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV.
by: PLOS Pathogens Staff
Published: (2016-07-01)

Assessing the impact of antiretroviral treatment interruption on progression of liver fibrosis in adults co-infected with HIV and hepatitus C
by: Thorpe, Julia
Published: (2010)

Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial.
by: Mark Holodniy, et al.
Published: (2011-03-01)